Home -> Law Blog Directory -> Class Action Blogs -> ClassLawBlog.com
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Class Action
: ClassLawBlog.comLabCorp Warned About Marketing Ovarian Cancer Test
By classlawblog
According to Medical News Today, on September 29, 2008, the U.S. Food and Drug Administration (FDA) issued a warning letter to the global clinical network, LabCorp for illegally marketing the ovarian cancer test, OvaSure.
In the warning letter, the FDA states LabCorp is in violation of the Food, Drug, and Cosmetic Act because the company does not have marketing clearance or approval from the FDA to market OvaSure. Within fifteen days of the receipt of the warning letter, LabCorp is required to notify the FDA of the specific steps the company has taken to correct the noted violations and the steps taken to prevent the recurrence of similar violations.
Full post as published by ClassLawBlog.com on October 14, 2008 (boomark / email).
Child Support
Disputing Paternity
Language Requirements for Citizenship
Naturalization without an English language test
Vytorin Marketing
alleged false claims in marketing campaign.
California Fertility Clinic Warned
For Not Screening for Sexually Transmitted Diseases
Pittsburgh Cancer Center
Wanrs of Cell Phone and Cancer Risk
Water Samples
Govert Well & Pump agrees to $100,000 settlement after failing to test for coliform bacteria.
Canadian Government
allegedly used Canadian soldier as test subjects for nuclear explosion radiation exposure.
Forest Laboratories Potentially Illegal Marketing
Forest Laboratories Potentially Illegal Marketing

Ovarian Cancer Test OvaSure Being Marketed Without Necessary FDA Approval
New Hope Sparked By Ovarian Cancer Test
F.D.A. Says Cancer Test Failed to Get Its Approval
LabCorp Illegally Markets Ovarian Cancer Test
FDA Concerned Over Ovarian Cancer Test OvaSure
Cancer Test for Women Raises Hope, and Concern








